Literature DB >> 4103275

Effects of lignocaine and propranolol on experimental cardiac arrhythmias.

J D Allen, R G Shanks, S A Zaidi.   

Abstract

1. The effects of intravenous injection of lignocaine and propranolol were studied in dogs.2. Ventricular ectopic beats produced by intravenous injection of adrenaline in anaesthetized dogs respired with halothane were abolished in four out of six dogs by lignocaine. Propranolol was effective in all three dogs tested.3. Intravenous infusion of lignocaine at (0.2 and 1.0 mg/kg)/min to total doses of 3.0 +/- 1.0 and 2.2 +/- 0.5 mg/kg, respectively, abolished the ventricular tachycardia produced in anaesthetized dogs by ouabain. A similar effect was produced by infusion of propranolol at (0.2 mg/kg)/min to a total dose of 1.9 +/- 0.4 mg/kg. Intravenous injection of single doses of lignocaine (4.0-8.0 mg/kg) also abolished the arrhythmia.4. The frequency of the ventricular ectopic beats occurring in conscious dogs 20-44 h after ligation of the anterior descending branch of the left coronary artery was reduced, with an increase in the number of sinus beats, after intravenous injection of lignocaine (8.0 mg/kg). Larger doses produced excitement. Propranolol (4.0 mg/kg) had a greater effect than the same dose of lignocaine but after 8.0 mg/kg, three of the four dogs died.5. Propranolol was more effective than lignocaine in abolishing the three different types of arrhythmia.6. Dose-response curves showed that lignocaine was more active in abolishing the ouabain induced arrhythmia than the halothane-adrenaline arrhythmia and was least active on the arrhythmia caused by ligation of the coronary artery.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4103275      PMCID: PMC1667002          DOI: 10.1111/j.1476-5381.1971.tb07081.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  New radiopaque mass for vascular injection.

Authors:  M J SCHLESINGER
Journal:  Lab Invest       Date:  1957 Jan-Feb       Impact factor: 5.662

2.  Comparison of some properties of pronethalol and propranolol.

Authors:  J W Black; W A Duncan; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1965-12

3.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

4.  Relative effectiveness of antiarrhythmic drugs in treatment of digitalis-induced ventricular tachycardia.

Authors:  K I Hilmi; T J Regan
Journal:  Am Heart J       Date:  1968-09       Impact factor: 4.749

5.  Effects of propranolol on the transmembrane potentials of ventricular muscle and Purkinje fibers of the dog.

Authors:  L D Davis; J V Temte
Journal:  Circ Res       Date:  1968-05       Impact factor: 17.367

6.  Effect of lidocaine on conduction in canine Purkinje fibers and at the ventricular muscle-Purkinje fiber junction.

Authors:  J T Bigger; W J Mandel
Journal:  J Pharmacol Exp Ther       Date:  1970-04       Impact factor: 4.030

7.  Electrophysiological actions of lidocaine on canine ventricular muscle and Purkinje fibers.

Authors:  L D Davis; J V Temte
Journal:  Circ Res       Date:  1969-05       Impact factor: 17.367

8.  Effect of propranolol on arrhythmias following coronary artery occlusion in dogs.

Authors:  R G Shanks; D Dunlop
Journal:  Cardiovasc Res       Date:  1967-01       Impact factor: 10.787

9.  Relationship between the uptake, binding and pharmacological action of procaine in the isolated heart.

Authors:  D J Boullin; T J Sullivan
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

10.  Effect of lidocaine on the electrophysiological properties of ventricular muscle and purkinje fibers.

Authors:  J T Bigger; W J Mandel
Journal:  J Clin Invest       Date:  1970-01       Impact factor: 14.808

View more
  5 in total

1.  Local anaesthetic and antiarrhythmic properties of an aminosteroid: 3alpha-dimethyl-amino-5alpha-androstan-2beta-ol-17-one (Org. NA 13).

Authors:  W R Buckett; F A Marwick
Journal:  Br J Pharmacol       Date:  1975-05       Impact factor: 8.739

2.  Effects of the myocardial-selective alpha 1-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs.

Authors:  A G Uprichard; D W Harron; R Wilson; R G Shanks
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

3.  Antiarrhythmic action of sparteine on direct and indirect models of cardiac fibrillation.

Authors:  J Senges; L Ehe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Effects of tiprenolol, practolol and propranolol on experimental ventricular tachyarrhythmias.

Authors:  J D Allen; R G Shanks
Journal:  Br J Pharmacol       Date:  1974-06       Impact factor: 8.739

5.  The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.

Authors:  J D Allen; J M Ekue; R G Shanks; S A Zaidi
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.